Home › Trial NCT07614048
Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS
- Trial IDNCT07614048
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorProvidence Health & Services
- Enrollment—
- Start date—
- ConditionsPDAC - Pancreatic Ductal Adenocarcinoma · Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.